
Am J Psychiatry 161:739-742, April 2004
© 2004 American Psychiatric Association
Serotonin1A Receptors at the Axon Initial Segment of Prefrontal Pyramidal Neurons in Schizophrenia
Dianne A. Cruz, M.S.,
Stephen M. Eggan, B.S.,
Efrain C. Azmitia, Ph.D., and
David A. Lewis, M.D.
OBJECTIVE: Inhibition mediated by -aminobutyric acid at the axon initial segment of pyramidal neurons appears to be altered in the prefrontal cortex in schizophrenia. This study examined the densities and laminar distribution of axon initial segments labeled with an antibody against the serotonin1A (5-HT1A) receptor, which also mediates inhibitory regulation of pyramidal neurons, in subjects with schizophrenia. METHOD: The densities and laminar distribution of axon initial segments with 5-HT1A-like immunoreactivity were assessed in postmortem tissue from the prefrontal cortex (Brodmanns area 46) of 14 matched triads of subjects with schizophrenia, subjects with major depressive disorder, and comparison subjects with no psychiatric disorder. RESULTS: The relative densities of the labeled axon initial segment in both the superficial and the deep cortical layers did not differ across the three subject groups. CONCLUSIONS: The findings do not support a role for altered serotonin transmission by means of the 5-HT1A receptor in dysfunction of prefrontal cortex pyramidal neurons in schizophrenia.
This article has been cited by other articles:

|
 |

|
 |
 
M. V. Puig, F. Artigas, and P. Celada
Modulation of the Activity of Pyramidal Neurons in Rat Prefrontal Cortex by Raphe Stimulation In Vivo: Involvement of Serotonin and GABA
Cereb Cortex,
January 1, 2005;
15(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|